Twin Lakes Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3K | Hold |
1,500
| – | – | 0.04% | 123 |
|
|
2025
Q1 | $45.3K | Hold |
1,500
| – | – | 0.03% | 129 |
|
|
2024
Q4 | $52.4K | Hold |
1,500
| – | – | 0.03% | 139 |
|
|
2024
Q3 | $60.1K | Hold |
1,500
| – | – | 0.04% | 131 |
|
|
2024
Q2 | $71.5K | Hold |
1,500
| – | – | 0.05% | 118 |
|
|
2024
Q1 | $65K | Hold |
1,500
| – | – | 0.04% | 126 |
|
|
2023
Q4 | $75.9K | Hold |
1,500
| – | – | 0.05% | 114 |
|
|
2023
Q3 | $68K | Hold |
1,500
| – | – | 0.05% | 118 |
|
|
2023
Q2 | $61.5K | Hold |
1,500
| – | – | 0.04% | 125 |
|
|
2023
Q1 | $53.6K | Hold |
1,500
| – | – | 0.04% | 128 |
|
|
2022
Q4 | $56.7K | Hold |
1,500
| – | – | 0.04% | 130 |
|
|
2022
Q3 | $66K | Buy |
+1,500
| New | +$66K | 0.05% | 123 |
|
|
2022
Q2 | – | Sell |
-1,500
| Closed | -$56K | – | 216 |
|
|
2022
Q1 | $56K | Hold |
1,500
| – | – | 0.03% | 149 |
|
|
2021
Q4 | $46K | Hold |
1,500
| – | – | 0.02% | 165 |
|
|
2021
Q3 | $50K | Hold |
1,500
| – | – | 0.03% | 152 |
|
|
2021
Q2 | $60K | Hold |
1,500
| – | – | 0.03% | 126 |
|
|
2021
Q1 | $67K | Buy |
+1,500
| New | +$67K | 0.04% | 116 |
|